Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Christine Walsh to Poly(ADP-ribose) Polymerase Inhibitors

This is a "connection" page, showing publications Christine Walsh has written about Poly(ADP-ribose) Polymerase Inhibitors.

 
Connection Strength
  
 
 
1.550
  
  1. Walsh C. Genetic Implications for Cancer Management: The Changing Landscape of Poly (ADP-ribose) Polymerase Inhibitor Indications in the Treatment of Ovarian Cancer. Clin Obstet Gynecol. 2024 Dec 01; 67(4):711-719.
    View in: PubMed
    Score: 0.850
  2. Walsh C. Targeted therapy for ovarian cancer: the rapidly evolving landscape of PARP inhibitor use. Minerva Ginecol. 2018 Apr; 70(2):150-170.
    View in: PubMed
    Score: 0.525
  3. Walsh C, Cass I. Poly(ADP-Ribose) Polymerase Inhibitors and Myeloid Neoplasm Risk-Clues to a Mechanistic Connection? JAMA Oncol. 2021 12 01; 7(12):1763-1765.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)